D.L. Carlson Investment Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,681
| Closed | -$2.77M | – | 140 |
|
|
2024
Q1 | $2.77M | Sell |
34,681
-1,156
| -3% | -$88.3K | 0.54% | 63 |
|
|
2023
Q4 | $2.75M | Sell |
35,837
-3,900
| -10% | -$278K | 0.56% | 57 |
|
|
2023
Q3 | $2.77M | Sell |
39,737
-26,653
| -40% | -$1.89M | 0.56% | 57 |
|
|
2023
Q2 | $4.59M | Sell |
66,390
-908
| -1% | -$64.6K | 0.88% | 40 |
|
|
2023
Q1 | $5M | Sell |
67,298
-18,545
| -22% | -$1.56M | 1.13% | 33 |
|
|
2022
Q4 | $8M | Sell |
85,843
-3,671
| -4% | -$354K | 1.71% | 16 |
|
|
2022
Q3 | $8.54M | Buy |
89,514
+304
| +0.3% | +$30.1K | 1.86% | 13 |
|
|
2022
Q2 | $8.27M | Buy |
89,210
+23,514
| +36% | +$2.29M | 1.74% | 13 |
|
|
2022
Q1 | $6.65M | Buy |
65,696
+3,255
| +5% | +$342K | 1.11% | 30 |
|
|
2021
Q4 | $6.44M | Buy |
62,441
+424
| +0.7% | +$39.2K | 1.03% | 36 |
|
|
2021
Q3 | $5.26M | Buy |
62,017
+330
| +0.5% | +$27.6K | 0.92% | 40 |
|
|
2021
Q2 | $5.15M | Buy |
+61,687
| New | +$5.05M | 0.89% | 44 |
|
|
2020
Q3 | – | Sell |
-37,201
| Closed | -$2.42M | – | 144 |
|
|
2020
Q2 | $2.42M | Sell |
37,201
-11,988
| -24% | -$755K | 0.72% | 53 |
|
|
2020
Q1 | $2.92M | Buy |
49,189
+20,270
| +70% | +$1.35M | 1.1% | 29 |
|
|
2019
Q4 | $2.15M | Buy |
+28,919
| New | +$2.03M | 0.62% | 58 |
|
|
2017
Q1 | – | Sell |
-46,894
| Closed | -$3.7M | – | 128 |
|
|
2016
Q4 | $3.7M | Sell |
46,894
-5,911
| -11% | -$478K | 1.26% | 23 |
|
|
2016
Q3 | $4.7M | Sell |
52,805
-4,002
| -7% | -$378K | 1.63% | 11 |
|
|
2016
Q2 | $5.44M | Sell |
56,807
-882
| -2% | -$87.9K | 1.94% | 5 |
|
|
2016
Q1 | $5.98M | Buy |
57,689
+3,560
| +7% | +$346K | 2.23% | 3 |
|
|
2015
Q4 | $5.29M | Buy |
54,129
+625
| +1% | +$61.2K | 1.97% | 4 |
|
|
2015
Q3 | $5.16M | Sell |
53,504
-3,930
| -7% | -$413K | 2.08% | 6 |
|
|
2015
Q2 | $6.02M | Sell |
57,434
-4,870
| -8% | -$498K | 2.18% | 4 |
|
|
2015
Q1 | $6.43M | Buy |
62,304
+650
| +1% | +$65.8K | 2.29% | 2 |
|
|
2014
Q4 | $5.94M | Sell |
61,654
-1,315
| -2% | -$116K | 2.14% | 4 |
|
|
2014
Q3 | $5.01M | Buy |
62,969
+3,502
| +6% | +$276K | 1.87% | 7 |
|
|
2014
Q2 | $4.48M | Buy |
59,467
+20,888
| +54% | +$1.58M | 1.63% | 9 |
|
|
2014
Q1 | $2.89M | Buy |
38,579
+23,350
| +153% | +$1.65M | 1.09% | 38 |
|
|
2013
Q4 | $1.09M | Sell |
15,229
-1,875
| -11% | -$120K | 0.4% | 81 |
|
|
2013
Q3 | $971K | Sell |
17,104
-476
| -3% | -$28.4K | 0.37% | 79 |
|
|
2013
Q2 | $1M | Buy |
+17,580
| New | +$1.02M | 0.4% | 76 |
|
Other funds holding CVS
D.L. Carlson Investment Group's CVS Position: Q2 2024 in Review
D.L. Carlson Investment Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 34,681 shares — an estimated $2.77M sold.
D.L. Carlson Investment Group first reported a position in CVS in Q2 2013 and held it in 30 quarters. The position peaked at $8.54M in Q3 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- D.L. Carlson Investment Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- D.L. Carlson Investment Group sold 34,681 CVS Health shares in Q2 2024, an estimated $2.77M.
- D.L. Carlson Investment Group first reported a position in CVS Health in Q2 2013 and held it in 30 quarters.
- D.L. Carlson Investment Group's CVS Health position peaked at $8.54M in Q3 2022.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on D.L. Carlson Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.